Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Net Income towards Common Stockholders: 2020-2025

Historic Net Income towards Common Stockholders for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to $20.2 million.

  • Cellebrite DI's Net Income towards Common Stockholders rose 109.75% to $20.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.3 million, marking a year-over-year increase of 124.09%. This contributed to the annual value of -$283.0 million for FY2024, which is 248.96% down from last year.
  • As of Q3 2025, Cellebrite DI's Net Income towards Common Stockholders stood at $20.2 million, which was up 3.66% from $19.5 million recorded in Q2 2025.
  • Over the past 5 years, Cellebrite DI's Net Income towards Common Stockholders peaked at $55.4 million during Q1 2022, and registered a low of -$207.1 million during Q3 2024.
  • In the last 3 years, Cellebrite DI's Net Income towards Common Stockholders had a median value of -$14.6 million in 2023 and averaged -$27.9 million.
  • Per our database at Business Quant, Cellebrite DI's Net Income towards Common Stockholders soared by 3,024.76% in 2021 and then slumped by 3,286.05% in 2024.
  • Over the past 5 years, Cellebrite DI's Net Income towards Common Stockholders (Quarterly) stood at $51.9 million in 2021, then slumped by 86.35% to $7.1 million in 2022, then plummeted by 306.94% to -$14.6 million in 2023, then spiked by 231.56% to $19.3 million in 2024, then spiked by 109.75% to $20.2 million in 2025.
  • Its Net Income towards Common Stockholders stands at $20.2 million for Q3 2025, versus $19.5 million for Q2 2025 and $17.4 million for Q1 2025.